Safety and Efficacy of CD10367 in Psoriasis Vulgaris

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This is an exploratory, single-centre, investigator blinded, randomized, controlled, intra-individual study, involving subjects with psoriasis vulgaris. The objective is to evaluate, in a modified Dumas-Scholtz psoriasis mini-zone test, the safety and efficacy of CD10367 solution at 1% and 3% after a 3-week treatment period of once daily application.
Epistemonikos ID: b1c5af44ca1de2c2b7603482db8b7bbbdff4549f
First added on: May 20, 2024